Regarding the mutator phenotype, we identified BRCA2 and NEIL3 to be associated with higher mutational burden (i.e., 20 mutations/tumor) in tumors in Caucasians (Supplementary data 2). This evidence concerns the gene BRCA2 and neoplasm.